All ESCMID Global 2026 articles
-
NewsMaternal RSV vaccination cuts infant hospitalization risk by over 80%, major study finds
The largest real-world study of its kind shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before birth.
-
NewsHIV treatment reduces accelerated biological ageing by nearly four years, landmark study shows
A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ageing in people with HIV (PWH) by nearly four years, a finding that could transform how clinicians monitor HIV treatment and long-term health outcomes.